Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
are ambitious, goal-oriented, collegial and motivated to tackle challenging new projects • Have PhD degree in (or in final stages to submit) in protein biochemistry/molecular biology/molecular
-
are ambitious, goal-oriented, collegial and motivated to tackle challenging new projects • Have PhD degree in (or in final stages to submit) in protein biochemistry/molecular biology/molecular
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
) in cell/molecular biology, parasitology, protein biochemistry or a similar field • prior experience in cultivation of Plasmodium falciparum is essential • expertise in genetic engineering (e.g
-
-throughput omics, molecular biology, drug library screens, characterization of the patient cohorts and the functional studies in experimental models. This is a new and exciting research field, with the goals
-
-throughput omics, molecular biology, drug library screens, characterization of the patient cohorts and the functional studies in experimental models. This is a new and exciting research field, with the goals
-
-scale computational approaches (molecular dynamics simulations, quantum chemistry, machine learning, etc) are applied to study the mechanistic aspects of biomolecules in great depth. The work is done in
-
provided in Rafa Najumudeen’s lab (http://najumudeenlab.com), located at Institute of Biotechnology, University of Helsinki, Finland. The lab is part of Institute of Molecular Medicine (FIMM) and Helsinki